Latest News- Epinephrine Autoinjector Market: 0.30gm is expected to lead the Type segment during 2024-2028

The Epinephrine Autoinjector Market is being driven by Increasing prevalence of allergies

The Epinephrine Autoinjector Market is expected to grow at a CAGR of 10.59% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.44 billion. The US epinephrine autoinjector market is poised for growth due to increasing pressure on the Food and Drug Administration (FDA) to approve more generic alternatives. With the recent price surge of Viatriss EpiPen, US authorities, such as Governor Margaret Wood Hassan, have urged the FDA to consider approving additional options. Companies like Bausch Health and ALK Abello, holding significant market shares in Europe, may capitalize on this initiative and enter the US market. For instance, Teva Pharmaceutical Industries launched the AJOVY in the prefilled YpsoMate 2 in March 2020. This government push for competition in the market is expected to lead to a substantial number of product launches during the forecast period. 

Get more information on Epinephrine Autoinjector Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • 0.30gm
  • 0.15gm
  • 0.50gm
• End-user
  • Hospitals
  • clinics
  • Homecare
• Age Group
  • 0 to 6 Years
  • 6 to 12 Years
  • Over 12 Years
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of allergies
• Rising innovations in marketing strategies by vendors
• Rise in awareness of anaphylaxis and availability of innovative epinephrine autoinjectors

However, the market also witnesses some limitations, which are as follows:

• Product recalls and regulatory issues
• High demand for substitutes of epinephrine autoinjectors in developing countries
• High cost of epinephrine autoinjector

Benefits of Buying Global Epinephrine Autoinjector Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Epinephrine Autoinjector Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Epinephrine Autoinjector market encompasses handheld devices like epinephrine pens and epipens, which deliver essential doses of epinephrine, also known as adrenaline, to individuals experiencing acute anaphylactic reactions due to allergic diseases, insect bites, or stings. These autoinjectors are crucial for severe allergic responses and are increasingly accepted by healthcare professionals and consumers. Companies like Amphastar Pharmaceuticals produce both branded and generic epinephrine autoinjectors, offering innovative needle-free injector technologies to cater to various age groups.

Market Research Overview

The Epinephrine Autoinjector market is a significant segment within the larger Global Healthcare Equipment Market, according to Technavio's market research. This market category encompasses businesses involved in the research and development (R&D), manufacturing, and distribution of epinephrine autoinjectors, which are essential medical devices used to treat acute anaphylactic reactions in various age groups suffering from allergic diseases. These injections are classified as consumables within the healthcare equipment industry, contributing to the overall market size, which includes the combined revenue generated by manufacturers of diagnostic equipment and devices across diverse therapy areas.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/